ESC 365 - A multifactorial porcine model of cardio-metabolic HFpEF highlights miR-483-3p as a promising target therapy

Open Access

A multifactorial porcine model of cardio-metabolic HFpEF highlights miR-483-3p as a promising target therapy

Session: Young Investigator Award (YIA) Basic Science

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Miss K. Kohlat (German Heart Center Of Charite Berlin, DE)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Miss Katharina Kohlat

German Heart Center Of Charite Berlin (Germany)

0 follower

3 more presentations in this session

Dapagliflozin in primary prevention of cardiotoxicity induced by anthracycline-trastuzumab therapy through activation of pAMPK and inhibition of MyD88 and NLRP-3

Speaker: Doctor V. Quagliariello (Naples, IT)

Engineering genetic resilience for cardiometabolic HFpEF: the crucial role of redox homeostasis

Speaker: Doctor M. Pepin (Stanford, US)

Phospholamban antisense therapy reduces phospholamban aggregation and enhances calcium and contractile kinetics in human phospholamban cardiomyopathy

Speaker: Mr F. Deiman (Groningen, NL)

Access the full session

Young Investigator Award (YIA) Basic Science

Speakers: Miss K. Kohlat, Doctor V. Quagliariello, Doctor M. Pepin, Mr F. Deiman

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources